562 related articles for article (PubMed ID: 30598172)
1. Strategies for Successful Management of Severe Atopic Dermatitis.
Brar KK; Nicol NH; Boguniewicz M
J Allergy Clin Immunol Pract; 2019 Jan; 7(1):1-16. PubMed ID: 30598172
[TBL] [Abstract][Full Text] [Related]
2. Dupilumab: A review of its use in the treatment of atopic dermatitis.
Gooderham MJ; Hong HC; Eshtiaghi P; Papp KA
J Am Acad Dermatol; 2018 Mar; 78(3 Suppl 1):S28-S36. PubMed ID: 29471919
[TBL] [Abstract][Full Text] [Related]
3. Relative efficacy of systemic treatments for atopic dermatitis.
Seger EW; Wechter T; Strowd L; Feldman SR
J Am Acad Dermatol; 2019 Feb; 80(2):411-416.e4. PubMed ID: 30296535
[TBL] [Abstract][Full Text] [Related]
4. Biologics for Atopic Dermatitis.
Boguniewicz M
Immunol Allergy Clin North Am; 2020 Nov; 40(4):593-607. PubMed ID: 33012322
[TBL] [Abstract][Full Text] [Related]
5. EASI p-EASI: Predicting disease severity in atopic dermatitis patients treated with dupilumab using a combination of serum biomarkers.
Bakker DS; Ariens LFM; Giovannone B; Hijnen D; Delemarre EM; Knol E; Nierkens S; de Bruin-Weller MS; Thijs JL; Drylewicz J
Allergy; 2020 Dec; 75(12):3287-3289. PubMed ID: 33305359
[No Abstract] [Full Text] [Related]
6. Effect of dupilumab on hand eczema in patients with atopic dermatitis: An observational study.
Oosterhaven JAF; Voorberg AN; Romeijn GLE; de Bruin-Weller MS; Schuttelaar MLA
J Dermatol; 2019 Aug; 46(8):680-685. PubMed ID: 31187925
[TBL] [Abstract][Full Text] [Related]
7. A life with atopic dermatitis: the patient's point of view after a new hope with dupilumab.
D'Adamio S; Massaro A; Biocca S; Bianchi L; Talamonti M; Galluzzo M
Clin Exp Dermatol; 2020 Aug; 45(6):809-810. PubMed ID: 32472943
[No Abstract] [Full Text] [Related]
8. Dupilumab Provides Rapid and Sustained Clinically Meaningful Responses in Adults with Moderate-to-severe Atopic Dermatitis.
Silverberg JI; Simpson EL; Boguniewicz M; De Bruin-Weller MS; Foley P; Kataoka Y; Bégo-Le-Bagousse G; Chen Z; Shumel B; Chao J; Rossi AB
Acta Derm Venereol; 2021 Nov; 101(11):adv00585. PubMed ID: 34618162
[TBL] [Abstract][Full Text] [Related]
9. Biologic Therapy for Atopic Dermatitis: Moving Beyond the Practice Parameter and Guidelines.
Boguniewicz M
J Allergy Clin Immunol Pract; 2017; 5(6):1477-1487. PubMed ID: 29122151
[TBL] [Abstract][Full Text] [Related]
10. Emerging Systemic Therapeutic Biologics and Small Molecules for Atopic Dermatitis: How to Decide Which Treatment Is Right for Your Patients.
Ahn J; Grinich EE; Choi Y; Guttman-Yassky E; Simpson EL
J Allergy Clin Immunol Pract; 2021 Apr; 9(4):1449-1460. PubMed ID: 33838838
[TBL] [Abstract][Full Text] [Related]
11. Current and Future Monoclonal Antibodies in the Treatment of Atopic Dermatitis.
Chun PIF; Lehman H
Clin Rev Allergy Immunol; 2020 Oct; 59(2):208-219. PubMed ID: 32617839
[TBL] [Abstract][Full Text] [Related]
12. Severe atopic dermatitis: Dupilumab is not just safer, but more efficient.
Giavina-Bianchi M; Rizzo LV; Giavina-Bianchi P
Allergol Immunopathol (Madr); 2020; 48(6):792-797. PubMed ID: 32249095
[TBL] [Abstract][Full Text] [Related]
13. A Review of Dupilumab in the Treatment of Atopic Dermatitis in Infants and Children.
Wang M; Gao XH; Zhang L
Drug Des Devel Ther; 2024; 18():941-951. PubMed ID: 38560522
[TBL] [Abstract][Full Text] [Related]
14. Effectiveness of dupilumab for the treatment of nummular eczema phenotype of atopic dermatitis in adults.
Patruno C; Stingeni L; Hansel K; Ferrucci SM; Tavecchio S; Fabbrocini G; Nisticò SP; Foti C; De Prezzo S; Napolitano M
Dermatol Ther; 2020 May; 33(3):e13290. PubMed ID: 32125741
[TBL] [Abstract][Full Text] [Related]
15. Diagnosis and Management of Dermatitis, Including Atopic, Contact, and Hand Eczemas.
Chan CX; Zug KA
Med Clin North Am; 2021 Jul; 105(4):611-626. PubMed ID: 34059241
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and safety of dupilumab monotherapy in adults with moderate-to-severe atopic dermatitis: a pooled analysis of two phase 3 randomized trials (LIBERTY AD SOLO 1 and LIBERTY AD SOLO 2).
Thaçi D; L Simpson E; Deleuran M; Kataoka Y; Chen Z; Gadkari A; Eckert L; Akinlade B; Graham NMH; Pirozzi G; Ardeleanu M
J Dermatol Sci; 2019 May; 94(2):266-275. PubMed ID: 31109652
[TBL] [Abstract][Full Text] [Related]
17. Update on Atopic Dermatitis: Diagnosis, Severity Assessment, and Treatment Selection.
Fishbein AB; Silverberg JI; Wilson EJ; Ong PY
J Allergy Clin Immunol Pract; 2020 Jan; 8(1):91-101. PubMed ID: 31474543
[TBL] [Abstract][Full Text] [Related]
18. The long-term effect of dupilumab on chronic hand eczema in patients with moderate to severe atopic dermatitis-52 week results from the Dutch BioDay Registry.
Voorberg AN; Romeijn GLE; de Bruin-Weller MS; Schuttelaar MLA
Contact Dermatitis; 2022 Aug; 87(2):185-191. PubMed ID: 35279856
[TBL] [Abstract][Full Text] [Related]
19. Modern therapies in atopic dermatitis: biologics and small molecule drugs.
Worm M; Francuzik W; Kraft M; Alexiou A
J Dtsch Dermatol Ges; 2020 Oct; 18(10):1085-1092. PubMed ID: 32666644
[TBL] [Abstract][Full Text] [Related]
20. Biologics for Treatment of Atopic Dermatitis: Current Status and Future Prospect.
Ratchataswan T; Banzon TM; Thyssen JP; Weidinger S; Guttman-Yassky E; Phipatanakul W
J Allergy Clin Immunol Pract; 2021 Mar; 9(3):1053-1065. PubMed ID: 33685604
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
